Blackstone Inc’s Merck MRK Stock Holding History

Blackstone Inc’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,571	Closed	-$1.14M	–	283
2025 Q3	$1.14M	Buy	+13,571	New	+$1.12M	﹤0.01%	186

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Blackstone Inc's MRK Position: Q4 2025 in Review

Blackstone Inc sold out of Merck (MRK) in Q4 2025, closing a stake of 13,571 shares — an estimated $1.14M sold.

Blackstone Inc first reported a position in MRK in Q3 2025 and held it in 1 quarter. The position peaked at $1.14M in Q3 2025. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

Blackstone Inc reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
Blackstone Inc sold 13,571 Merck shares in Q4 2025, an estimated $1.14M.
Blackstone Inc first reported a position in Merck in Q3 2025 and held it in 1 quarter.
Blackstone Inc's Merck position peaked at $1.14M in Q3 2025.
3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Blackstone Inc's 13F filing for Q4 2025, filed 17 Feb 2026.